Unity Biotechnology, Inc. UBX
Set alert
0.20 0.00 0.00%
At close · Jul 2
0.2001 Day range 0.2001
0.947 52-week range 2.02
- YTD
- -79.51%
- 1 year
- -84.95%
- Open
- 0.2001
- Prev close
- 0.2001
- Mkt cap
- 16.85M
- Vol
- 0
- Avg vol
- 67.22K
- EPS
- -1.28
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2001
- High
- 0.2001
- Forward P/E
- -0.57
- Beta
- 0.83
- Short ratio
- 3.52
- Inst. own
- 20.55%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 6, 2024
- 50-d avg
- 1.24
- 200-d avg
- 1.43
- 1y target
- 7.00
6M chart
Signals (18)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Jul 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 30, 2025 | 1 year ago |
| RSI: Oversold | Jun 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| MACD: Buy Signal | May 27, 2025 | 1 year ago |
| RSI: Oversold | May 14, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 14, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| RSI: Oversold | Mar 31, 2025 | 1 year ago |
| SMA: Bearish | Mar 24, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 24, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 14, 2025 | 1 year ago |
| SMA: Bearish | Feb 27, 2025 | 1 year ago |
| SMA: Bullish | Feb 26, 2025 | 1 year ago |
| SMA: Bearish | Feb 25, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 5, 2025 | 1 year ago |
Analyst view
Consensus: none
Price target (mean) 7.00 +3398.3% upside
Now 0.2001
- Target (low)
- 6.00
- Target (mean)
- 7.00
- Target (high)
- 8.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.43443 | -0.43443 – -0.43443 | -0.28 | -55.1% | 0 | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.34 | 0.0% | 0 | 0.0% | 0 |
| Current year | -1.47 | -1.47 – -1.47 | -2.70 | +45.4% | 0 | 0.0% | 1 |
| Next year | -1.71 | -1.71 – -1.71 | -1.47 | -15.9% | 0 | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 16, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 16, 2023 | Wedbush | Upgrade | Neutral | Outperform |
| Nov 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 9, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 26, 2023 | Wedbush | Downgrade | Outperform | Neutral |
| May 31, 2023 | Roth MKM | Initiated | — | Buy |
| May 26, 2023 | Citigroup | Maintained | Buy | Buy |
| May 10, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 25, 2023 | Wedbush | Maintained | — | Outperform |
| Mar 28, 2023 | Mizuho | Maintained | — | Buy |
| Mar 28, 2023 | Wedbush | Maintained | — | Outperform |
| Mar 28, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 28, 2023 | Citigroup | Maintained | — | Buy |
| Mar 16, 2023 | Wedbush | Reiterated | — | Outperform |
| Mar 16, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 15, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 16, 2022 | Mizuho | Maintained | — | Buy |
| Nov 9, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 2, 2022 | Wedbush | Maintained | — | Outperform |